Inflammation-related gene polymorphisms associated with Parkinson’s disease: an updated meta-analysis
Open Access
- 6 April 2020
- journal article
- research article
- Published by Springer Nature in Egyptian Journal of Medical Human Genetics
- Vol. 21 (1) , 1-10
Abstract
Background: Strong evidence supports the involvement of inflammation processes in the development and progression of Parkinson’s disease (PD), where increasingly correlations have been identified between genetic variations in inflammation-related genes and PD. However, data varies between studies. Therefore, we conducted a meta-analysis to clarify associations between inflammation-related gene polymorphisms and PD risk. Methods: All studies were identified through online databases. Pooled and stratified groups based on racial descent were assembled to evaluate associations between polymorphisms and PD. Results: The pooled results showed that protective effects for PD were observed for (1) IL-1α -889 C/T in Asian populations (T vs. C, OR = 0.831, P = 0.031; TT + CT vs. CC, OR = 0.827, P = 0.049); (2) IL-6 -176 G/C in Caucasian populations (CC + GC vs. GG, OR = 0.656, P = 0.000; GC vs. GG, OR = 0.673, P = 0.000); (3) IL-8 -251 A/T (T vs. A, OR = 0.812, P = 0.041; TT vs. AT + AA, OR = 0.663, P = 0.012), particularly in Caucasian populations (TT vs. AT + AA, OR = 0.639, P = 0.010); (4) IL-10 -819 T/C (C vs. T, OR = 0.742, P = 0.034); (5) IL-18 -607 C/A (AA + CA vs. CC, OR = 0.597, P = 0.015; CA vs. CC, OR = 0.534, P = 0.005), and (6) CCR2 +190 G/A (AA vs. GA + GG, OR = 0.552, P = 0.018; AA vs. GG; OR = 0.554; 95% CI 0.336–0.914, P = 0.005). An increased risk of PD was associated with IL-10 -1082 G/A in Asian populations (A vs. G, OR = 1.731, P = 0.000; AA + GA vs. GG, OR = 1.910, P = 0.000). No significant associations with PD were observed for polymorphisms in IL-1β -511 C/T, IL-10 -592 C/A, IL-18 -137 G/C, TNFα -863 C/A, TNFα -857 C/T, TNFα -308 G/A, IFNΥ +874 T/A, and MCP1/CCL2 +2518 A/G. Conclusions: We suggest that IL-1α -889, IL-6 -176, IL-8 -251, IL-10 -1082, IL-10 -819, IL-18 -607, and CCR2 +190 polymorphisms may be associated with PD risk; however, further studies must verify these conclusions.Keywords
This publication has 50 references indexed in Scilit:
- Dopamine and the Brainstem Locomotor Networks: From Lamprey to HumanFrontiers in Neuroscience, 2017
- Interleukin-10 promoter polymorphisms in Chinese patients with Parkinson's diseaseNeuroscience Letters, 2012
- Gender differences in the IL6 −174G>C and ESR2 1730G>A polymorphisms and the risk of Parkinson's diseaseNeuroscience Letters, 2012
- Interleukin-18 promoter polymorphisms and risk of Parkinson's disease in a Han Chinese populationBrain Research, 2011
- Lack of association between IL-1β, TNF-α, and IL-10 gene polymorphisms and sporadic Parkinson’s disease in an Italian cohortActa Neurologica Scandinavica, 2010
- Lack of association between interleukin-1 alpha, beta polymorphisms and Parkinson's diseaseNeuroscience Letters, 2010
- Protective role of interlekin-1 alpha gene polymorphism in Chinese Han population with sporadic Parkinson’s diseaseNeuroscience Letters, 2008
- Interleukin-1α polymorphism has influence on late-onset sporadic Parkinson’s disease in TaiwanJournal of Neural Transmission, 2007
- Interaction of polymorphisms in the genes encoding interleukin‐6 and estrogen receptor beta on the susceptibility to Parkinson's diseaseAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2005
- Genetic analysis of immunomodulating factors in sporadic Parkinson's diseaseJournal of Neural Transmission, 2000